We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

73 hedge funds and large institutions have $45.9M invested in Mustang Bio in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

91% more capital invested

Capital invested by funds: $24M → $45.9M (+$21.9M)

14% more funds holding

Funds holding: 64 → 73 (+9)

0.01% more ownership

Funds ownership: 0.03% → 0.04% (+0.01%)

56% less call options, than puts

Call options by funds: $147K | Put options by funds: $334K

Holders
73
Holders Change
+9
Holders Change %
+14.06%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
27
Reduced
10
Closed
7
Calls
$147K
Puts
$334K
Net Calls
-$187K
Net Calls Change
-$65K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$6M
2
ECM
Endurant Capital Management
California
+$2.4M
3
Millennium Management
Millennium Management
New York
+$2.38M
4
SSA
Schonfeld Strategic Advisors
New York
+$1.21M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$675K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$281K
3
Renaissance Technologies
Renaissance Technologies
New York
-$217K
4
BlackRock
BlackRock
New York
-$70.1K
5
Simplex Trading
Simplex Trading
Illinois
-$65.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$52K – – –
SG Americas Securities
52
SG Americas Securities
New York
$50K +$16.4K +7 +50%
Barclays
53
Barclays
United Kingdom
$50K +$21K +9 +75%
SAG
54
Spotlight Asset Group
Illinois
$49K – – –
FAM
55
Fenimore Asset Management
New York
$48K – – –
PPA
56
Parametric Portfolio Associates
Washington
$47K +$2.34K +1 +5%
Deutsche Bank
57
Deutsche Bank
Germany
$44K +$14K +6 +46%
SFS
58
Sowell Financial Services
Arkansas
$41K +$39.7K +17 New
Two Sigma Investments
59
Two Sigma Investments
New York
$41K +$39.7K +17 New
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$32K – – –
Bank of America
61
Bank of America
North Carolina
$32K +$9.35K +4 +40%
Group One Trading
62
Group One Trading
Illinois
$32K +$30.4K +13 New
TRCT
63
Tower Research Capital (TRC)
New York
$20K +$7.01K +3 +60%
PHK
64
Point72 Hong Kong
Hong Kong
$18K +$16.4K +7 New
Russell Investments Group
65
Russell Investments Group
United Kingdom
$18K +$18.7K +8 New
Legal & General Group
66
Legal & General Group
United Kingdom
$15K – – –
Citigroup
67
Citigroup
New York
$12K -$14K -6 -55%
APA
68
American Portfolios Advisors
New York
$12K – – –
GWM
69
Geneos Wealth Management
Colorado
$10K – – –
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$8K +$4.68K +2 +200%
Carson Wealth (CWM LLC)
71
Carson Wealth (CWM LLC)
Nebraska
$7K – – –
AIP
72
Ameritas Investment Partners
Nebraska
$5K – – –
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
$4.8K -$23.4K -10 -83%
TF
74
TimeScale Financial
Massachusetts
$1K – – –
O
75
OrbiMed
New York
– -$675K -336 Closed
1 2
3
4

MBIO Hedge Fund Activity: Q2 2020 in Review

73 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2020, worth a combined $45.9M — up 91% from $24M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MBIO positions and 7 closed out — a net gain of 10 holders — while 27 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $6M. The largest seller was OrbiMed, exiting entirely with an estimated $675K sold.

  • 73 institutional investors held Mustang Bio (MBIO) as of Q2 2020, up from 64 in Q1 2020.
  • Funds reported $45.9M of Mustang Bio stock for Q2 2020, up 91% quarter-over-quarter.
  • 17 funds opened new Mustang Bio positions in Q2 2020 and 7 closed out, a net change of +10 holders.
  • The largest Mustang Bio buyer in Q2 2020 was JP Morgan Chase, an estimated $6M added.
  • The largest Mustang Bio seller in Q2 2020 was OrbiMed, an estimated $675K sold.

Based on aggregated 13F filings for Q2 2020.